BioTheryX patents IL-1beta, IL-6, IL-2 and TNF-alpha production inhibitors March 20, 2019 No Comments
Bridge Medicines signs agreement with Weill Cornell Medicine to develop novel S1P receptor modulator March 12, 2019 No Comments
Sunshine Lake Pharma identifies new semicarbazide-sensitive amine oxidase inhibitors Feb. 28, 2019 No Comments
Generation of a novel nucleoside inhibitor for the treatment of ischemia-reperfusion injury Feb. 28, 2019 No Comments